Seth Miller

DBL Partners invests in private growth companies with a strong emphasis on investments in Clean Tech as well as investments in Information Technology, Sustainability-Oriented Products and Services and Healthcare. The firm's Double Bottom Line investment strategy is to invest in companies that can deliver top-tier venture capital returns (First Bottom Line) and while working with thier companies to enable social, environmental and economic improvement in the regions in which they operate (Second Bottom Line).

Tekla Capital Management LLC is the investment adviser for four closed-end equity funds: Tekla Healthcare Investors, Tekla Life Sciences Investors, Tekla Health Care Opportunities Fund and Tekla World Healthcare Fund. The funds invest in public and private growth equities in the healthcare and life sciences industries.Tekla Healthcare Investors (HQH) is a broadly diversified closed-end healthcare fund that invests primarily in biotechnology, medical devices and pharmaceuticals. The fund seeks to provide long-term capital appreciation through investments in companies in the health technology industries that have the potential for above-average long-term growth. The fund focuses on smaller, emerging companies with no more than 40% of its assets invested in the restricted securities of public and private companies. The fund is somewhat larger than Tekla Sciences Investors.Tekla Life Sciences Investors (HQL) is a broadly diversified closed-end healthcare fund that invests primarily in biotechnology, medical devices and pharmaceuticals. The fund seeks to provide long-term capital appreciation through investments in companies in the health technology industries that have the potential for above-average long-term growth. The fund is more focused on life science technology than Tekla Healthcare Investors, expanding the biotechnology focus to include investments in agricultural biotechnology and environmental technology, focusing on smaller, emerging companies with no more than 40% of its assets invested in the restricted securities of public and private companies. Both funds invest in small, emerging growth companies but Tekla Life Science's holdings tend to be somewhat smaller and slightly more volatile.Tekla Healthcare World Fund (TWH) is a non-diversified closed-end fund that invests primarily in the healthcare industry. The Fund's objective is to seek current income and long-term capital appreciation through investment companies engaged in the healthcare industry, including equity securities, debt securities and pooled investment vehicles.Tekla Healthcare Opportunities Fund (THQ) is a non-diversified closed-end fund that seeks current income and long-term capital appreciation through investment companies engaged in the healthcare industry, including equity securities, debt securities and pooled investment vehicles.